{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T04:15:49Z","timestamp":1747196149284,"version":"3.40.5"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T00:00:00Z","timestamp":1629936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Genetic variants in microRNAs (miRNAs) can alter the miRNAs expression and\/or function, accordingly, affecting the related biological pathways and disease risk. Dysregulation of miR-155 and miR-146a expression levels has been well-described in viral hepatitis B (HBV). In the current study, we aimed to assess rs767649 T\/A and rs57095329 A\/G polymorphisms in miR-155, and miR-146a genes, respectively, as risk factors for Chronic HBV (CHBV) in the Egyptian population. Also, we aimed to do in silico analysis to investigate the molecules that primarily target these miRNAs. One hundred patients diagnosed as CHBV and one hundred age and sex-matched controls with evidence of past HBV infection were genotyped for miR-155 (rs767649) and miR-146a (rs57095329) using real-time polymerase chain reaction. The rs767649 AT and AA genotypes in CHBV patients confer four folds and ten folds risk respectively, as compared to control subjects [(AOR = 4.245 (95%CI 2.009\u20138.970), <jats:italic>p<\/jats:italic>&lt;0.0001) and AOR = 10.583 (95%CI 4.012\u201327.919), <jats:italic>p<\/jats:italic>&lt;0.0001, respectively)]. The rs767649 A allele was associated with an increased risk of developing CHBV (AOR = 2.777 (95%CI 1.847\u20134.175), <jats:italic>p<\/jats:italic>&lt;0.0001). There was a significant difference in the frequency of rs57095329 AG and GG genotypes in CHBV patients compared to controls. AG and GG genotypes showed an increase in the risk of developing CHBV by about three and six folds respectively [AOR = 2.610 (95%CI 1.362\u20135.000), <jats:italic>p<\/jats:italic> = 0.004] and [AOR = 5.604 (95%CI 2.157\u201314.563), <jats:italic>p<\/jats:italic>&lt;0.0001].We concluded that rs57095329 and rs767649 SNPs can act as potential risk factors for the development of CHBV in the Egyptian population.<\/jats:p>","DOI":"10.1371\/journal.pone.0256724","type":"journal-article","created":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T17:55:20Z","timestamp":1630000520000},"page":"e0256724","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["miR-155 T\/A (rs767649) and miR-146a A\/G (rs57095329) single nucleotide polymorphisms as risk factors for chronic hepatitis B virus infection among Egyptian patients"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9363-3998","authenticated-orcid":true,"given":"Enas M.","family":"Hefzy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noha A.","family":"Hassuna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olfat G.","family":"Shaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Masoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tebyan A.","family":"Abelhameed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarek I.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nada F.","family":"Hemeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed A.","family":"Abdelhakeem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6876-992X","authenticated-orcid":true,"given":"Rania H.","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2021,8,26]]},"reference":[{"issue":"6","key":"pone.0256724.ref001","doi-asserted-by":"crossref","first-page":"e99724","DOI":"10.1371\/journal.pone.0099724","article-title":"A genome-wide association study on chronic HBV infection and its clinical progression in male Han-Taiwanese","volume":"9","author":"SW Chang","year":"2014","journal-title":"PloS one"},{"issue":"3","key":"pone.0256724.ref002","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.3892\/ol.2016.4884","article-title":"Significance of the hedgehog pathway-associated proteins Gli-1 and Gli-2 and the epithelial-mesenchymal transition-associated proteins Twist and E-cadherin in hepatocellular carcinoma","volume":"12","author":"HW Chun","year":"2016","journal-title":"Oncol. Lett"},{"issue":"4","key":"pone.0256724.ref003","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.trsl.2011.01.007","article-title":"MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases","volume":"157","author":"R Dai","year":"2011","journal-title":"Transl Res"},{"issue":"12","key":"pone.0256724.ref004","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1111\/liv.13469","article-title":"Hepatitis B in Egypt: A cross\u2010sectional analysis of prevalence and risk factors for active infection from a nationwide survey","volume":"37","author":"SA Ismail","year":"2017","journal-title":"Liver Int"},{"issue":"37","key":"pone.0256724.ref005","doi-asserted-by":"crossref","first-page":"60303","DOI":"10.18632\/oncotarget.11206","article-title":"MiR-155 and its functional variant rs767649 contribute to the susceptibility and survival of hepatocellular carcinoma","volume":"7","author":"J Ji","year":"2016","journal-title":"Oncotarget"},{"issue":"2","key":"pone.0256724.ref006","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00109-004-0603-7","article-title":"Regulatory polymorphisms underlying complex disease traits. \"","volume":"83","author":"JC Knight","year":"2005","journal-title":"J. Mol. Med"},{"issue":"4","key":"pone.0256724.ref007","doi-asserted-by":"crossref","first-page":"e0121918","DOI":"10.1371\/journal.pone.0121918","article-title":"Meta-analysis of microRNA-146a rs2910164 G> C polymorphism association with autoimmune diseases susceptibility, an update based on 24 studies","volume":"10","author":"C Li","year":"2015","journal-title":"PloS one"},{"issue":"3","key":"pone.0256724.ref008","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/gene.2011.84","article-title":"Genetic association of miRNA-146a with systemic lupus erythematosus in Europeans through decreased expression of the gene","volume":"13","author":"SE L\u00f6fgren","year":"2012","journal-title":"Genes Immun"},{"issue":"6","key":"pone.0256724.ref009","doi-asserted-by":"crossref","first-page":"e1002128","DOI":"10.1371\/journal.pgen.1002128","article-title":"A functional variant in microRNA-146a promoter modulates its expression and confers disease risk for systemic lupus erythematosus","volume":"7","author":"X Luo","year":"2011","journal-title":"PLoS Genet"},{"journal-title":"MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology, and individualized medicine","author":"PJ Mishra","key":"pone.0256724.ref010"},{"issue":"5824","key":"pone.0256724.ref011","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1126\/science.1139253","article-title":"Requirement of bic\/microRNA-155 for normal immune function","volume":"316","author":"A Rodriguez","year":"2007","journal-title":"Science"},{"issue":"1","key":"pone.0256724.ref012","first-page":"1","article-title":"Ectopic expression of microRNA-155 enhances innate antiviral immunity against HBV infection in human hepatoma cells","volume":"8","author":"C Su","year":"2011","journal-title":"Virol. J"},{"issue":"11","key":"pone.0256724.ref013","first-page":"15177","article-title":"Predictive role of miR-146a rs2910164 (C> G), miR-149 rs2292832 (T> C), miR-196a2 rs11614913 (T> C) and miR-499 rs3746444 (T> C) in the development of hepatocellular carcinoma","volume":"8","author":"P Yan","year":"2015","journal-title":"Int. j. clin. exp. pathol"},{"key":"pone.0256724.ref014","first-page":"2011","article-title":"MiR-146a in immunity and disease","author":"N Rusca","year":"2011","journal-title":"Mol bio internat"},{"key":"pone.0256724.ref015","doi-asserted-by":"crossref","first-page":"578","DOI":"10.3389\/fimmu.2014.00578","article-title":"MicroRNA-146a: a dominant, negative regulator of the innate immune response","volume":"5","author":"R Saba","year":"2014","journal-title":"Front. Immunol"},{"issue":"6","key":"pone.0256724.ref016","first-page":"4670","article-title":"MicroRNA-146a regulates the transformation from liver fibrosis to cirrhosis in patients with hepatitis B via interleukin-6.","volume":"17","author":"Z Yang","year":"2019","journal-title":"ExpTher Med."},{"issue":"3","key":"pone.0256724.ref017","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nri1573","article-title":"Immunology of hepatitis B virus and hepatitis C virus infection","volume":"5","author":"B Rehermann","year":"2005","journal-title":"Nat. Rev. Immunol"},{"issue":"9","key":"pone.0256724.ref018","doi-asserted-by":"crossref","first-page":"558","DOI":"10.4254\/wjh.v10.i9.558","article-title":"Micro-RNAs in hepatitis B virus-related chronic liver diseases and hepatocellular carcinoma","volume":"10","author":"E Sagnelli","year":"2018","journal-title":"World J Hepatol"},{"issue":"4","key":"pone.0256724.ref019","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3390\/jpm9040051","article-title":"Potential impact of microRNA gene polymorphisms in the pathogenesis of diabetes and atherosclerotic cardiovascular disease","volume":"9","author":"I Elfaki","year":"2019","journal-title":"J. Pers. Med"},{"issue":"48","key":"pone.0256724.ref020","doi-asserted-by":"crossref","first-page":"6228","DOI":"10.1038\/onc.2008.300","article-title":"NF-\u03baB signaling, liver disease and hepatoprotective agents","volume":"27","author":"B Sun","year":"2008","journal-title":"Oncogene"},{"issue":"1","key":"pone.0256724.ref021","first-page":"146","article-title":"miR\u2010155: an ancient regulator of the immune system","volume":"253","author":"E Vigorito","year":"2013","journal-title":"Immunolrev"},{"issue":"10","key":"pone.0256724.ref022","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/jvh.12390","article-title":"Expression of microRNA\u2010155 correlates positively with the expression of Toll\u2010like receptor 7 and modulates hepatitis B virus via C\/EBP\u2010\u03b2 in hepatocytes","volume":"22","author":"N Sarkar","year":"2015","journal-title":"J Viral Hepat"},{"key":"pone.0256724.ref023","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.3389\/fimmu.2017.01173","article-title":"Lower expression of MicroRNA-155 contributes to dysfunction of natural killer cells in patients with chronic hepatitis B","volume":"8","author":"J Ge","year":"2017","journal-title":"Front Immunol"},{"issue":"20","key":"pone.0256724.ref024","doi-asserted-by":"crossref","first-page":"7269","DOI":"10.1073\/pnas.0802682105","article-title":"Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma","volume":"105","author":"K Jazdzewski","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"pone.0256724.ref025","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1136\/annrheumdis-2012-201627","article-title":"MicroRNA-146a and Ets-1 gene polymorphisms in ocular Beh\u00e7et\u2019s disease and Vogt\u2013Koyanagi\u2013Harada syndrome","volume":"73","author":"Q Zhou","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"pone.0256724.ref026","doi-asserted-by":"crossref","first-page":"293","DOI":"10.4049\/jimmunol.1202100","article-title":"MicroRNA-146a feedback suppresses T cell immune function by targeting Stat1 in patients with chronic hepatitis B","volume":"191","author":"S Wang","year":"2013","journal-title":"J. Immunol"},{"issue":"2","key":"pone.0256724.ref027","article-title":"Upregulation of microRNA-146a by hepatitis B virus X protein contributes to hepatitis development by downregulating complement factor H","volume":"6","author":"JF Li","year":"2015","journal-title":"MBio"},{"key":"pone.0256724.ref028","article-title":"The functional polymorphisms of miR-146a are associated with susceptibility to severe sepsis in the Chinese population","author":"Y Shao","year":"2014","journal-title":"Mediators Inflamm"},{"issue":"2","key":"pone.0256724.ref029","first-page":"126","article-title":"Serum levels of miRNA in patients with hepatitis B virus-associated acute-on-chronic liver failure","volume":"17","author":"Y Wen","year":"2018","journal-title":"HBPD INT"},{"issue":"1","key":"pone.0256724.ref030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-8722-5-13","article-title":"The emerging role of MIR-146A in the control of hematopoiesis, immune function and cancer","volume":"5","author":"C Labbaye","year":"2012","journal-title":"J. Hematol. Oncol"},{"issue":"4","key":"pone.0256724.ref031","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-3083.2010.02383.x","article-title":"MicroRNA\u2010146a and human disease","volume":"71","author":"L Li","year":"2010","journal-title":"Scand J Immunol"},{"issue":"1","key":"pone.0256724.ref032","first-page":"1","article-title":"Inferring microRNA and transcription factor regulatory networks in heterogeneous data","volume":"14","author":"TD Le","year":"2013","journal-title":"BMC bioinformatics"},{"issue":"4","key":"pone.0256724.ref033","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jiph.2019.01.061","article-title":"Validity of hepatitis B and hepatitis C case definitions","volume":"12","author":"Z Dakic","year":"2019","journal-title":"J infect Public Health"},{"issue":"1","key":"pone.0256724.ref034","first-page":"S1","article-title":"AliBaba2: context specific identification of transcription factor binding sites","volume":"2","author":"N Grabe","year":"2002","journal-title":"In Silico Biol"},{"issue":"D1","key":"pone.0256724.ref035","doi-asserted-by":"crossref","first-page":"D930","DOI":"10.1093\/nar\/gkr917","article-title":"HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants","volume":"40","author":"LD Ward","year":"2012","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"pone.0256724.ref036","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1101\/gr.137323.112","article-title":"Annotation of functional variation in personal genomes using RegulomeDB","volume":"22","author":"AP Boyle","year":"2012","journal-title":"Genome res"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0256724","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T17:56:17Z","timestamp":1630000577000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0256724"}},"subtitle":[],"editor":[{"given":"Isabelle","family":"Chemin","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,8,26]]},"references-count":36,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0256724","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2021,8,26]]}}}